Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)

Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial pr...

Descripción completa

Detalles Bibliográficos
Autores principales: López‐Cuevas, Paco, Xu, Can, Severn, Charlotte E., Oates, Tiah C. L., Cross, Stephen J., Toye, Ashley M., Mann, Stephen, Martin, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762276/
http://dx.doi.org/10.1002/advs.202270226
_version_ 1784852829907714048
author López‐Cuevas, Paco
Xu, Can
Severn, Charlotte E.
Oates, Tiah C. L.
Cross, Stephen J.
Toye, Ashley M.
Mann, Stephen
Martin, Paul
author_facet López‐Cuevas, Paco
Xu, Can
Severn, Charlotte E.
Oates, Tiah C. L.
Cross, Stephen J.
Toye, Ashley M.
Mann, Stephen
Martin, Paul
author_sort López‐Cuevas, Paco
collection PubMed
description Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial protocells that can circulate in blood and deliver reprogramming cargoes to immune cells to enhance their anti‐cancer potential. [Image: see text]
format Online
Article
Text
id pubmed-9762276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97622762022-12-20 Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022) López‐Cuevas, Paco Xu, Can Severn, Charlotte E. Oates, Tiah C. L. Cross, Stephen J. Toye, Ashley M. Mann, Stephen Martin, Paul Adv Sci (Weinh) Back Cover Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial protocells that can circulate in blood and deliver reprogramming cargoes to immune cells to enhance their anti‐cancer potential. [Image: see text] John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC9762276/ http://dx.doi.org/10.1002/advs.202270226 Text en © 2022 Wiley‐VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Back Cover
López‐Cuevas, Paco
Xu, Can
Severn, Charlotte E.
Oates, Tiah C. L.
Cross, Stephen J.
Toye, Ashley M.
Mann, Stephen
Martin, Paul
Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title_full Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title_fullStr Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title_full_unstemmed Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title_short Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
title_sort macrophage reprogramming with anti‐mir223‐loaded artificial protocells enhances in vivo cancer therapeutic potential (adv. sci. 35/2022)
topic Back Cover
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762276/
http://dx.doi.org/10.1002/advs.202270226
work_keys_str_mv AT lopezcuevaspaco macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT xucan macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT severncharlottee macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT oatestiahcl macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT crossstephenj macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT toyeashleym macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT mannstephen macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022
AT martinpaul macrophagereprogrammingwithantimir223loadedartificialprotocellsenhancesinvivocancertherapeuticpotentialadvsci352022

Ejemplares similares